Back to today’s briefing

Story perspectives

Study Reveals 10% of Seniors Face Blood Cancer Risk

6/24/2025

46 4

Summary

Story summary

A groundbreaking study from Vanderbilt University Medical Center uncovers that 10% of people over 70 could face clonal hematopoiesis of indeterminate potential (CHIP), heightening their risk for blood cancer. Particularly alarming, those with cytopenia are ten times more likely to see disease progression. Regular blood count checks could pave the way for timely interventions and better clinical trial results for these vulnerable patients.

1 of 1

Story summary

A groundbreaking study from Vanderbilt University Medical Center uncovers that 10% of people over 70 could face clonal hematopoiesis of indeterminate potential (CHIP), heightening their risk for blood cancer. Particularly alarming, those with cytopenia are ten times more likely to see disease progression. Regular blood count checks could pave the way for timely interventions and better clinical trial results for these vulnerable patients.